Talis Biomedical Corp
NASDAQ:TLIS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Talis Biomedical Corp
Free Cash Flow
Talis Biomedical Corp
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
Free Cash Flow
-$53.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Free Cash Flow
$3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$1.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
102%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$2.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$4.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$595.8m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-1%
|
See Also
What is Talis Biomedical Corp's Free Cash Flow?
Free Cash Flow
-53.7m
USD
Based on the financial report for Dec 31, 2023, Talis Biomedical Corp's Free Cash Flow amounts to -53.7m USD.
What is Talis Biomedical Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-20%
Over the last year, the Free Cash Flow growth was 47%. The average annual Free Cash Flow growth rates for Talis Biomedical Corp have been 17% over the past three years , -20% over the past five years .